| 19668-3 |
PHENobarbital cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
PHENobarbital cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19668-3 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Phenobarb CtO Ur Scn-mCnc |
|
|
|
Y |
|
Barbiturate; c417; CtO; DRUG/TOXICOLOGY; Drugs; Level; Luminal; Mass concentration; Nirvonal; PHBR; Phenobarb; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 19669-1 |
PHENobarbital cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
PHENobarbital cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19669-1 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Phenobarb CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Barbiturate; c417; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Luminal; Mass concentration; Nirvonal; PHBR; Phenobarb; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 1967-9 |
Bile acid |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Bile acid [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
ug/dL |
|
|
|
|
|
|
CHEM |
|
1967-9 |
|
|
|
|
Both |
|
|
|
0 |
Bile Ac Ser-mCnc |
|
|
|
Y |
|
Acd; Acids; Bile acid.total; Bile salt; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1 |
|
|
|
|
|
|
|
ug/dL |
|
|
|
0 |
| 19670-9 |
Phenothiazines |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Phenothiazines [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19670-9 |
|
Screen |
|
|
Both |
|
|
|
0 |
Phenothiaz Ur Ql Scn |
|
|
|
|
|
Dibenzothiazine; DRUG/TOXICOLOGY; Drugs; Ordinal; Phenothiaz; Phenothiazine; Phenothiazn; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
Changed component name from "Phenothiazine" (singular) to "Phenothiazines" (pleural) to better reflect its long term intended meaning and current conventions. . Phenothiazine is a distinct chemical but has never been used in human medicine. (It was used for parasitic diseases in animals decades ago but not now). The word phenothiazine has always been used to mean the class of drugs that are derived from phenothiazine and laboratories that use phenothiazine and phenothiazines to mean the measure of any drug of phenothiazine class contained in the specimen.; The scale has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 19672-5 |
Phenothiazines cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Phenothiazines cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19672-5 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Phenothiaz CtO Ur Scn-mCnc |
|
|
|
Y |
|
CtO; Dibenzothiazine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Phenothiaz; Phenothiazine; Phenothiazn; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.52 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
Changed component name from "Phenothiazine" (singular) to "Phenothiazines" (pleural) to better reflect its long term intended meaning and current conventions. . Phenothiazine is a distinct chemical but has never been used in human medicine. (It was used for parasitic diseases in animals decades ago but not now). The word phenothiazine has always been used to mean the class of drugs that are derived from phenothiazine and laboratories that use phenothiazine and phenothiazines to mean the measure of any drug of phenothiazine class contained in the specimen. |
0 |
| 19673-3 |
Phenothiazines cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Phenothiazines cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19673-3 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Phenothiaz CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Dibenzothiazine; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Phenothiaz; Phenothiazine; Phenothiazn; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.52 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
Changed component name from "Phenothiazine" (singular) to "Phenothiazines" (pleural) to better reflect its long term intended meaning and current conventions. . Phenothiazine is a distinct chemical but has never been used in human medicine. (It was used for parasitic diseases in animals decades ago but not now). The word phenothiazine has always been used to mean the class of drugs that are derived from phenothiazine and laboratories that use phenothiazine and phenothiazines to mean the measure of any drug of phenothiazine class contained in the specimen. |
0 |
| 19674-1 |
Phentermine |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Phentermine [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19674-1 |
|
Screen |
|
|
Both |
|
|
|
0 |
Phentermine Ur Ql Scn |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ionamin; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 19676-6 |
Phentermine cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Phentermine cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19676-6 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Phentermine CtO Ur Scn-mCnc |
|
|
|
Y |
|
CtO; DRUG/TOXICOLOGY; Drugs; Ionamin; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 19677-4 |
Phentermine cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Phentermine cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19677-4 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Phentermine CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; Ionamin; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 19678-2 |
Prazepam |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Prazepam [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19678-2 |
|
Screen |
|
|
Both |
|
|
|
0 |
Prazepam Ur Ql Scn |
|
|
|
|
|
Centrax; Demetrin; DRUG/TOXICOLOGY; Drugs; Lysanxia; Mono-detrimin; Ordinal; Point in time; PR; Prazene; QL; Qual; Qualitative; Random; Reapam; Scn; Scr; Screen; Scrn; Trepidan; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 19679-0 |
Prazepam |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
Prazepam [Presence] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19679-0 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Prazepam Ur Ql Cfm |
|
|
|
|
|
Centrax; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Demetrin; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Lysanxia; Mono-detrimin; Ordinal; Point in time; PR; Prazene; QL; Qual; Qualitative; Random; Reapam; Screen; Trepidan; UA; UR; Urn |
2.73 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 1968-7 |
Bilirubin.glucuronidated+Bilirubin.albumin bound |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Bilirubin.direct [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
1968-7 |
|
|
|
|
Both |
|
|
|
0 |
Bilirub Direct SerPl-mCnc |
|
|
|
Y |
|
Alb; Associated; Bc; Bili; Bili.delta; Bili-alb; Bilirub Conj; Bilirub Delta; Bilirub Direct; Bilirubin conjugated; Bilirubin direct; Bilirubin glucuronides; Bilirubins; Billirubin; bnd; Chemistry; DELB; Delta bilirubin; Deltab; Hematology; Heme; Hepatology; Level; Liver; Mass Concentration; Pl; Plasma; Plsm; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBIL; TBIL-(Bu+Bc); TBIL-Bu; UniversalLabOrders |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
154 |
| 19680-8 |
Prazepam cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Prazepam cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19680-8 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Prazepam CtO Ur Scn-mCnc |
|
|
|
Y |
|
Centrax; CtO; Demetrin; DRUG/TOXICOLOGY; Drugs; Level; Lysanxia; Mass concentration; Mono-detrimin; Point in time; Prazene; QNT; Quan; Quant; Quantitative; Random; Reapam; Scn; Scr; Scrn; Trepidan; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 19681-6 |
Prazepam cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Prazepam cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19681-6 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Prazepam CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Centrax; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Demetrin; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Lysanxia; Mass concentration; Mono-detrimin; Point in time; Prazene; QNT; Quan; Quant; Quantitative; Random; Reapam; Trepidan; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 19682-4 |
Psilocin |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Psilocin [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19682-4 |
|
Screen |
|
|
Both |
|
|
|
0 |
Psilocin Ur Ql Scn |
|
|
|
|
|
4-hydroxy-dimethyltryptamine; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 19683-2 |
Psilocin |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
Psilocin [Presence] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19683-2 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Psilocin Ur Ql Cfm |
|
|
|
|
|
4-hydroxy-dimethyltryptamine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 19684-0 |
Psilocin cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Psilocin cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19684-0 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Psilocin CtO Ur Scn-mCnc |
|
|
|
Y |
|
4-hydroxy-dimethyltryptamine; CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 19685-7 |
Psilocin cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Psilocin cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19685-7 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Psilocin CtO Ur Cfm-mCnc |
|
|
|
Y |
|
4-hydroxy-dimethyltryptamine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 19686-5 |
Psilocybin |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Psilocybin [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19686-5 |
|
Screen |
|
|
Both |
|
|
|
0 |
Psilocybin Ur Ql Scn |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 19687-3 |
Psilocybin |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
Psilocybin [Presence] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19687-3 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Psilocybin Ur Ql Cfm |
|
|
|
|
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 19688-1 |
Psilocybin |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Psilocybin [Mass/volume] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19688-1 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Psilocybin Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 19689-9 |
Psilocybin |
MCnc |
Urine |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Psilocybin [Mass/volume] in Urine |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
19689-9 |
|
|
|
|
|
|
|
|
0 |
Deprecated Psilocybin Ur-mCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.36 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 1969-5 |
Bilirubin renal clearance |
VRat |
Urine+Ser/Plas |
24H |
Qn |
|
|
ACTIVE |
Bilirubin.total renal clearance in 24 hour Urine and Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mL/min |
|
|
|
|
|
|
CHEM |
|
1969-5 |
|
|
|
|
Both |
|
|
|
0 |
Bilirub Cl 24h Ur+SerPl-vRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Bili; Bilirubins; Billirubin; Chemistry; Cl; Clear; Clearanc; Clearances; Clr; Flow; Kidney; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBIL; UA; UR; Ur+SerPl; Urn; Volume rate; vRate |
2.66 |
1 |
|
|
|
|
|
|
|
mL/min |
|
|
|
0 |
| 19690-7 |
Psilocybin cutoff |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Psilocybin cutoff [Mass/volume] in Urine for Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19690-7 |
|
Screen |
|
|
Observation |
|
|
|
0 |
Psilocybin CtO Ur Scn-mCnc |
|
|
|
Y |
|
CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 19691-5 |
Psilocybin cutoff |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Psilocybin cutoff [Mass/volume] in Urine for Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
19691-5 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Psilocybin CtO Ur Cfm-mCnc |
|
|
|
Y |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.44 |
1.0l |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
